Medico Remedies Limited

Web: medicoremedies.com NSE: MEDICO BSE: 540937 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

39 0(0%)

Volume

2L as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

69/100

Growth Score

81/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

327

No. of Shares

8.3

P/E

52.19

P/B

7.65

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

14.66

ROCE

Profit Growth

Listing Date

26-May-22

Promoter Holding

61.38%

FII Holding

0.08%

DII Holding

Price Chart

Price Performance

1 Week2%

1 Month13%

3 Months19%

6 Months2%

1 Year2%

YTD2%

Moving Average

5 Day SMA43

10 Day SMA43

20 Day SMA45

30 Day SMA45

50 Day SMA43

61 Day SMA42

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	44	43	44	44
Resistance 2	44	43	43	44
Resistance 1	43	42	43	43
Pivot Point	43	42	43	43
Support 1	42	42	42	42
Support 2	41	42	42	41
Support 3	41	42	41	40

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 61.38%	(0.01) 61.38%	(0.01) 61.38%	(-1.21) 61.38%	(-1.21) 62.59%	(-3.01) 63.79%	(-6.51) 66.83%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%
FIIs	(0.11) 0.08%	(-0.51) 0.03%	(0.21) 0.49%	(0.21) 0.30%	(0.01) 0.07%	(-0.31) 0.11%	(0.21) 0.39%	(0.01) 0.22%	(-0.11) 0.22%	(-1.01) 0.29%	(0.21) 1.29%	(-0.11) 1.11%	(0.71) 1.19%	(0.51) 0.53%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.01%	(-0.81) 0.01%	(-0.21) 0.78%	(0.01) 0.97%	(0.21) 0.97%	(0.71) 0.74%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	38.55%	38.60%	38.13%	38.30%	37.33%	36.08%	32.00%	25.47%	25.46%	25.63%	25.36%	25.55%	25.46%	26.15%	26.66%	26.65%	26.66%	26.66%	26.66%	26.66%
No. of Shareholders	15,863	16,189	16,562	18,503	16,474	15,424	14,104	12,887	12,902	10,685	6,052	5,264	5,055	3,287	1,777	778	501	119	120	89

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	69.4	56.81	58.68	52.64	38.25	41.3	39.49	39.35	30.8	41.32	29.77	42.36	31.47	27.99	38.85	40.46	33.14	32.28	30.13	29.54
Sales Growth % (YoY)	81%	38%	49%	34%	24%	-	33%	-7%	-2%	48%	-23%	5%	-5%	-13.3%	28.9%	37%	14%	-	-	-
Sales Growth % (QoQ)	22.2%	-3.2%	11.5%	37.6%	-7.4%	4.6%	0.4%	27.8%	-25.5%	38.8%	-29.7%	34.6%	12.4%	-28%	-4%	22.1%	2.7%	7.1%	2%	-
Expenses	66.1	49.66	54.35	49.91	35.43	34.64	36.38	36.94	27.98	36.67	27.04	39.29	29.01	24.82	35.46	37.32	33.32	29.64	28.21	27.37
Operating Profit	3.3	7.15	4.33	2.73	2.82	6.66	3.11	2.41	2.82	4.65	2.73	3.07	2.46	3.17	3.39	3.14	-0.18	2.64	1.92	2.17
OPM %	4.76	12.59	7.38	5.19	7.37	16.13	7.88	6.12	9.16	11.25	9.17	7.25	7.82	11.33	8.73	7.76	-0.54	8.18	6.37	7.35
Other Income	1.17	2.87	0.68	1.72	0.66	0.29	1.43	0.68	0.29	0.58	0.27	0.96	0.31	0.04	0.86	1.55	1.6	0.74	0.23	0.8
Interest	0.41	0.9	0.39	0.24	0.28	0.49	0.28	0.21	0.18	0.25	0.22	0.18	0.17	0.21	0.2	0.17	0.17	0.13	0.2	0.17
Depreciation	0.72	0.8	0.79	0.73	0.77	0.77	0.76	0.75	0.75	0.74	0.72	0.71	0.71	0.73	0.74	0.66	0.59	0.88	0.44	0.47
Profit before tax	3.34	8.32	3.83	3.48	2.43	5.69	3.5	2.13	2.18	4.24	2.06	3.14	1.89	2.27	3.31	3.86	0.66	2.37	1.51	2.33
Tax %	24.55	29.69	25.07	25.86	25.51	23.9	25.14	27.23	27.06	26.89	30.1	22.61	29.63	22.47	32.33	25.65	43.94	20.25	33.11	27.9
Net Profit	2.52	5.86	2.87	2.57	1.82	4.34	2.62	1.55	1.58	3.1	1.45	2.43	1.32	1.77	2.25	2.87	0.36	1.88	1.01	1.68
Net Profit Growth % (QoQ)	-57%	104.2%	11.7%	41.2%	-58.1%	65.6%	69%	-1.9%	-49%	113.8%	-40.3%	84.1%	-25.4%	-21.3%	-21.6%	697.2%	-80.9%	86.1%	-39.9%	-
Net Profit Growth % (YoY)	38.5%	35%	9.5%	65.8%	15.2%	40%	80.7%	-36.2%	19.7%	75.1%	-35.6%	-15.3%	266.7%	-5.9%	122.8%	70.8%	-	-	-	-
TTM Net Profit	13.82	13.12	11.6	11.35	10.33	10.09	8.85	7.68	8.56	8.3	6.97	7.77	8.21	7.25	7.36	6.12	4.93	4.57	2.69	0
EPS in Rs	0.3	0.71	0.35	0.31	0.22	0.52	0.32	0.19	0.19	0.37	0.17	0.29	0.16	0.21	0.27	0.35	0.04	0.23	0.12	0.2

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	206	151	145	140	121	122	89	98	61	54	67	51	45	34
Sales Growth %	36.7%	4.2%	3.2%	16%	-1.1%	38.1%	-9.3%	60.1%	12.2%	-18.4%	30.8%	13.7%	33%	-
Expenses	189	136	132	131	114	117	86	95	58	50	63	48	43	32
Operating Profit	17	15	13	10	7	5	3	3	3	4	4	3	2	1
OPM %	8	10	9	7	6	4.3	3.2	2.8	6	7	5	6	5	4
Other Income	6	3	2	4	2	1	2	2	1	0	0	0	0	0
Interest	2	1	1	1	1	1	1	1	2	1	1	1	1	0
Depreciation	3	3	3	3	2	2	2	2	1	1	1	1	1	0
Profit before tax	18	14	11	10	6	4	2	2	2	2	2	1	1	1
Tax %	27	25	27	28	26	30	26	28	35	4	40	28	34	40
Net Profit	13	10	8	7	5	3	2	2	1	2	1	1	1	0
Net Profit Growth %	30%	25%	14.3%	40%	66.7%	50%	-	100%	-50%	100%	-	-	-	-
EPS in Rs	1.58	1.22	1	0.87	0.58	0.31	0.2	0.19	0.15	0.25	0.35	0.25	0.25	0.21
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	6	5	2	8	6	-11	1	5	5	-3
Cash from Investing Activity	-5	-3	-3	-7	-2	-17	-3	-4	-5	-3
Cash from Financing Activity	-1	-1	0	-2	-6	18	3	-1	-1	6
Net Cash Flow	1	1	-1	0	-2	-10	0	0	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	17	17	17	17	17	17	17	4	4	4	4	3	2	2	1	1
Reserves	59	50	46	39	36	27	20	28	26	24	23	13	13	12	7	4
Borrowings	19	13	15	11	8	10	13	15	14	14	13	19	14	8	8	6
Other Liabilities	59	58	43	32	36	34	28	28	32	35	20	13	17	14	14	8
Total Liabilities	153	137	120	99	96	87	77	76	75	76	59	48	46	36	31	18
Fixed Assets	20	21	21	21	21	22	18	15	13	12	7	7	7	8	8	4
CWIP	3	0	0	0	0	0	0	0	2	1	4	3	0	0	0	0
Investments	2	2	2	0	2	1	0	1	0	0	0	0	1	1	0	1
Other Assets	129	114	96	78	73	64	59	59	60	63	48	39	38	27	23	14
Total Assets	153	137	120	99	96	87	77	76	75	76	59	48	46	36	31	18

Delivery

Delivery Data: MEDICO

#	Date	37 41% 51	Value (Cr)	Q/T 333	Del 51	Del 2
1	4-Sep	40	0	70	51	0
2	3-Sep	40	0	58	56	0
3	2-Sep	39	3	156	23	1
4	1-Sep	39	4	109	49	2
5	31-Aug	42	1	285	86	1
6	28-Aug	42	1	167	75	1
7	27-Aug	43	1	141	70	0
8	26-Aug	42	0	115	61	0
9	25-Aug	42	2	303	48	1
10	24-Aug	42	0	86	54	0
11	21-Aug	43	1	111	37	0
12	20-Aug	42	0	89	54	0
13	19-Aug	43	0	56	46	0
14	18-Aug	43	1	118	70	0
15	17-Aug	44	1	114	61	1
16	14-Aug	46	3	168	56	1
17	13-Aug	48	5	610	50	3
18	12-Aug	47	2	328	36	1
19	11-Aug	45	1	463	15	0
20	10-Aug	46	3	478	24	1
21	7-Aug	47	2	422	36	1
22	6-Aug	48	2	335	23	0
23	5-Aug	49	3	453	36	1
24	4-Aug	49	9	550	39	4
25	3-Aug	50	3	307	47	2
26	31-Jul	49	2	355	33	1
27	30-Jul	48	3	357	38	1
28	29-Jul	46	2	245	49	1
29	28-Jul	44	4	340	42	2
30	27-Jul	41	2	491	28	0
31	24-Jul	38	0	86	63	0
32	23-Jul	38	0	97	63	0
33	22-Jul	38	0	57	68	0
34	21-Jul	39	0	79	42	0
35	20-Jul	38	0	102	54	0
36	17-Jul	39	0	241	79	0
37	16-Jul	39	1	320	80	1
38	15-Jul	39	0	64	53	0
39	14-Jul	39	0	105	73	0
40	13-Jul	39	0	118	62	0
41	10-Jul	40	0	191	65	0
42	9-Jul	39	0	58	53	0
43	8-Jul	39	0	61	48	0
44	7-Jul	40	0	85	52	0
45	6-Jul	40	0	92	57	0
46	3-Jul	41	1	85	54	0
47	2-Jul	40	2	164	50	1
48	1-Jul	40	1	124	41	0
49	30-Jun	39	2	284	62	1
50	29-Jun	40	0	79	41	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	327c	2c	0.45
03-Sep	329c	22c	6.19
01-Sep	350c	41L	0.12
31-Aug	351c	5c	1.29
27-Aug	346c	3c	0.86
26-Aug	349c	5c	1.45
25-Aug	344c	5c	1.50
24-Aug	349c	4c	1.17
21-Aug	353c	3c	0.95
19-Aug	357c	3c	0.89
18-Aug	354c	15c	4.12
17-Aug	369c	3c	0.78
14-Aug	372c	29c	7.13
13-Aug	400c	8c	2.10
12-Aug	392c	12c	3.03
10-Aug	381c	4c	0.95
07-Aug	384c	17c	4.14
06-Aug	401c	3c	0.79
05-Aug	398c	3c	0.66
04-Aug	400c	66L	0.17
03-Aug	401c	6c	1.37
31-Jul	407c	32c	8.46
30-Jul	375c	10c	2.78
29-Jul	365c	4c	1.01
28-Jul	361c	15c	4.47
27-Jul	346c	31c	9.81
24-Jul	315c	0	0

Stock Checklist

Price is above from 52 week high low average: 34%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView